Advantage Trust Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $352K | Buy |
4,245
+500
| +13% | +$41.5K | 0.17% | 46 |
|
|
2025
Q1 | $304K | Sell |
3,745
-900
| -19% | -$73K | 0.18% | 35 |
|
|
2024
Q4 | $418K | Sell |
4,645
-1,200
| -21% | -$108K | 0.25% | 30 |
|
|
2024
Q3 | $577K | Sell |
5,845
-600
| -9% | -$59.3K | 0.39% | 23 |
|
|
2024
Q2 | $598K | Hold |
6,445
| – | – | 0.43% | 22 |
|
|
2024
Q1 | $612K | Hold |
6,445
| – | – | 0.45% | 22 |
|
|
2023
Q4 | $575K | Buy |
+6,445
| New | +$575K | 0.45% | 21 |
|